ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors

Geoffrey Richard, Stéphane Dalle, Marie‐Ambre Monet, Maud Ligier, Amélie Boespflug, Roxane M Pommier, Arnaud de la Fouchardière, Marie Perier‐Muzet, Lauriane Depaepe, Romain Barnault, Garance Tondeur, Stéphane Ansieau, Emilie Thomas, Corine Bertolotto, Robert Ballotti, Samia Mourah, Maxime Battistella, Céleste Lebbé, Luc Thomas, Alain Puisieux, Julie Caramel

Open source

DOI: 10.15252/emmm.201505971
Published: 2016-09-05
Container: EMBO Molecular Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15252/emmm.201505971,
  title = {ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors},
  author = {Geoffrey Richard and Stéphane Dalle and Marie‐Ambre Monet and Maud Ligier and Amélie Boespflug and Roxane M Pommier and Arnaud de la Fouchardière and Marie Perier‐Muzet and Lauriane Depaepe and Romain Barnault and Garance Tondeur and Stéphane Ansieau and Emilie Thomas and Corine Bertolotto and Robert Ballotti and Samia Mourah and Maxime Battistella and Céleste Lebbé and Luc Thomas and Alain Puisieux and Julie Caramel},
  year = {2016},
  journal = {EMBO Molecular Medicine},
  doi = {10.15252/emmm.201505971},
  url = {https://doi.org/10.15252/emmm.201505971}
}

RIS

TY  - JOUR
TI  - ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
AU  - Geoffrey Richard
AU  - Stéphane Dalle
AU  - Marie‐Ambre Monet
AU  - Maud Ligier
AU  - Amélie Boespflug
AU  - Roxane M Pommier
AU  - Arnaud de la Fouchardière
AU  - Marie Perier‐Muzet
AU  - Lauriane Depaepe
AU  - Romain Barnault
AU  - Garance Tondeur
AU  - Stéphane Ansieau
AU  - Emilie Thomas
AU  - Corine Bertolotto
AU  - Robert Ballotti
AU  - Samia Mourah
AU  - Maxime Battistella
AU  - Céleste Lebbé
AU  - Luc Thomas
AU  - Alain Puisieux
AU  - Julie Caramel
PY  - 2016
JO  - EMBO Molecular Medicine
DO  - 10.15252/emmm.201505971
UR  - https://doi.org/10.15252/emmm.201505971
ER  -

APA

Richard, G., Dalle, S., Monet, M., Ligier, M., Boespflug, A., Pommier, R. M., Fouchardière, A. D. L., Perier‐Muzet, M., Depaepe, L., Barnault, R., Tondeur, G., Ansieau, S., Thomas, E., Bertolotto, C., Ballotti, R., Mourah, S., Battistella, M., Lebbé, C., Thomas, L., Puisieux, A., & Caramel, J. (2016). ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201505971

Source records

crossref · retrieved 2026-11-08T15:13:58.938Z